ArticleJournal of postgraduate medicine2026
Trichosporon fungemia in critically ill patients: A case series.
Article in Journal of postgraduate medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractTrichosporon species are emerging opportunistic pathogens capable of causing a spectrum of disease, from superficial skin infections to deep-seated, disseminated, and life-threatening infections. These infections are often challenging to diagnose due to their rarity, frequent misidentification as Candida , and intrinsic resistance to conventional antifungal therapies, resulting in delays in appropriate management. We report a case series of Trichosporon fungemia in six critically ill patients, highlighting varied clinical presentations. Common comorbidities included diabetes mellitus, hypertension, anemia, hypothyroidism, sepsis, multiorgan dysfunction, and complications related to indwelling devices. All cases had blood culture-confirmed Trichosporon fungemia. The overall mortality was 66.7% (4/6 cases). Our findings emphasize the importance of early recognition, prompt antifungal therapy, and strict infection control measures to improve outcomes in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.